Results 31 to 40 of about 1,591,450 (336)

In silico analysis of differentially expressed genesets in metastatic breast cancer identifies potential prognostic biomarkers

World Journal of Surgical Oncology, 2021
Background Identification of specific biological functions, pathways, and appropriate prognostic biomarkers is essential to accurately predict the clinical outcomes of and apply efficient treatment for breast cancer patients.
Jongchan Kim
doaj   +1 more source

The Metabolic Mechanisms of Breast Cancer Metastasis

Frontiers in Oncology, 2021
Breast cancer is one of the most common malignancy among women worldwide. Metastasis is mainly responsible for treatment failure and is the cause of most breast cancer deaths.
Lingling Wang, Lingling Wang, Shizhen Zhang, Xiaochen Wang   +3 more
doaj   +1 more source

Protein analysis of extracellular vesicles to monitor and predict therapeutic response in metastatic breast cancer

Nature Communications, 2021
Molecular profiling of circulating extracellular vesicles (EVs) provides a promising noninvasive means to diagnose, monitor, and predict the course of metastatic breast cancer (MBC).
Fei Tian, Shaohua Zhang, Chao Liu, Ziwei Han, Yuan Liu, Jinqi Deng, Yike Li, Xia Wu, Lili Cai, Lili Qin, Qinghua Chen, Yang Yuan, Yi Liu, Y. Cong, Baoquan Ding, Zefei Jiang, Jiashu Sun   +16 more
semanticscholar   +1 more source

Development, implementation and evaluation of an online course on evidence-based healthcare for consumers

BMC Health Services Research, 2020
Background Evidence-based healthcare (EBHC) principles are essential knowledge for patient and consumer (“consumer”) engagement as research and research implementation stakeholders.
Genie Han, Musa Mayer, Joseph Canner, Kristina Lindsley, Reva Datar, Jimmy Le, Annette Bar-Cohen, Janice Bowie, Kay Dickersin   +8 more
doaj   +1 more source

Serum atrial natriuretic peptide: a suspected biomarker of breast cancer

Contemporary Oncology, 2017
Aim of the study : To assess serum levels of ANP in breast cancer female patients and its relationship to metastasis and some clinical parameters among those patients.
Maha E. Houssen, Hayam F. Ghazy, Kamel Farag, Mona Abo Bakr El-Hussiny, Mohamed A. El Ghaffar, Sahar Alsayed Mohamed Alsayed, Omar Farouk   +6 more
doaj   +1 more source

Engineered macrophages as near-infrared light activated drug vectors for chemo-photodynamic therapy of primary and bone metastatic breast cancer

Nature Communications, 2021
Patients with primary and bone metastatic breast cancer have significantly reduced survival and life quality. Due to the poor drug delivery efficiency of anti-metastasis therapy and the limited response rate of immunotherapy for breast cancer, effective ...
Yanjuan Huang, Zilin Guan, Xiuling Dai, Yifeng Shen, Qinhe Wei, Lingling Ren, Jingwen Jiang, Zhanghong Xiao, Yali Jiang, Di Liu, Zeqian Huang, Xiaoyu Xu, Yongquan Luo, Chunshun Zhao   +13 more
semanticscholar   +1 more source

Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue

International Journal of Molecular Sciences, 2021
Breast cancer, specifically metastatic breast, is a leading cause of morbidity and mortality in women. This is mainly due to relapse and reoccurrence of tumor.
Vrinda Gote, A. Nookala, Pradeep Kumar Bolla, D. Pal   +3 more
semanticscholar   +1 more source

Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer.

New England Journal of Medicine, 2019
BACKGROUND Patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer who have disease progression after therapy with multiple HER2-targeted agents have limited treatment options. Tucatinib is an investigational, oral,
R. Murthy, S. Loi, A. Okines, E. Paplomata, E. Hamilton, S. Hurvitz, N. Lin, V. Borges, V. Abramson, C. Anders, P. Bedard, Mafalda Oliveira, E. Jakobsen, T. Bachelot, S. S. Shachar, V. Müller, S. Braga, F. Duhoux, R. Greil, D. Cameron, L. Carey, G. Curigliano, K. Gelmon, G. Hortobagyi, I. Krop, S. Loibl, M. Pegram, D. Slamon, M. C. Palanca-Wessels, L. Walker, W. Feng, E. Winer   +31 more
semanticscholar   +1 more source

Emerging Intrinsic Therapeutic Targets for Metastatic Breast Cancer

Biology, 2023
Breast cancer is now the most common cancer worldwide, and it is also the main cause of cancer-related death in women. Survival rates for female breast cancer have significantly improved due to early diagnosis and better treatment.
Jiawei Li, Eyleen L. K. Goh, Ji He, Yan Li, Zhimin Fan, Zhigang Yu, Peng Yuan, Dong-Xu Liu   +7 more
doaj   +1 more source

Lin28B-high breast cancer cells promote immune suppression in the lung pre-metastatic niche via exosomes and support cancer progression

Nature Communications, 2022
The formation of pre-metastatic niche is a key step in the metastatic burden. The pluripotent factor Lin28B is frequently expressed in breast tumors and is particularly upregulated in the triple negative breast cancer subtype.
M. Qi, Yun Xia, Yanjun Wu, Zhuo Zhang, Xinyu Wang, Liying Lu, Cheng Dai, Yanjie Song, Keying Xu, Weiwei Ji, L. Zhan   +10 more
semanticscholar   +1 more source